FiercePharmaOriginal article
{"a":[{"_":"Teva saddles up as stalking horse bidder for bankrupt BioXcel’s neuroscience portfolio","$":{"href":"/biotech/teva-saddles-stalking-horse-bidder-bankrupt-bioxcels-neuroscience-portfolio","hreflang":"en"}}]}
Negative
AI Analysis
Summary
BioXcel Therapeutics has filed for bankruptcy with Teva Pharmaceutical acting as stalking horse bidder to acquire its neuroscience portfolio assets for $57.5 million upfront.
Outcome Details
Stalking horse bidder agreement for neuroscience portfolio acquisition
Importance:7/10
Sentiment:
-0.30
bankruptcyacquisitionasset purchaseneurosciencestalking horse
Read the original article
Published by FiercePharma on August 28, 2026 9:17 AM